Reduced daunomycin accumulation in drug-sensitive and multidrug- resistant human carcinoma KB cells following phorbol ester treatment: A potential role for protein kinase C in reducing drug influx

Oncology Research

Volumn 8, Issue 6, 1996, Pages 249-257

  Drew, Lisa ^a   Groome, Nigel ^b   Warr, J Roger ^a   Rumsby, Martin G ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

daunomycin accumulation; multidrug resistance; phorbol ester; protein kinase C

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4ALPHA PHORBOL 13 ACETATE 12 MYRISTATE; DAUNORUBICIN; DIMETHYL SULFOXIDE; GLYCOPROTEIN P; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN KINASE C; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL STRAIN KB; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SENSITIVITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0029966245     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. 1. Juliano, R. L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455:152-162; 1976.
2. 2. Ueda, K.; Cornwell, M. M.; Gottesman, M. M; Pastan, I.; Roninson, I. B., Ling, V.; Riordan, J. R. The mdr-1 gene, responsible for multidrug resistance, codes for P-glycoprotein. Biochem. Biophys. Res Commun. 141: 956-962; 1986.
3. 3. Horio, M.; Gottesman, M. M.; Pastan, I. ATP-dependent transport of vinblastine in vesicles from human multidrug resistant cells. Proc. Natl. Acad. Sci. USA 85: 3580-3584; 1988.
4. 4. O'Brian, C. A.; Far, D.; Ward, N. E.; Seud, C.; Fidler, I. J. Level of protein kinase activity correlates directly with resistance to Adriamycin in murine fibrosarcoma cells. FEBS Lett. 246:78-82; 1989.
5. 5. Posada, J. A.; McKeegan, E. N.; Worthington, K. F.; Morin, N. J.; Jaken, S.; Tritton, T. R. Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance. Cancer Commun. 1:285-292; 1989.
6. 6. Lee, A. A.; Karaszkiewicz, J. W.; Anderson, W. B. Elevated level of protein kinase C in multidrug resistant MCF-7 human breast carcinoma cells. Cancer Res. 52:3750-3759; 1992.
7. 7. Gollapudi, S.; Patel, K.; Jain, V.; Gupta, S. Protein kinase C isoforms in multidrug resistant murine leukemia P388/ADR cells; a possible role in daunorubicin transport. Cancer Lett. 62:69-75; 1992.
8. 8. Chambers, T. C.; Pohl, J.; Raynor, R. L.; Kuo, J. F. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J. Biol. Chem. 268:4592-4595; 1993.
9. 9. Orr, G. A.; Han, E. K. H.; Browne, P. C.; Nieves, E.; Olonnor, B. M.; Yang, C. P. H.; Horwitz, S. B. Identification of the major phosphorylation domain of murine MDR1B P-glycoprotein. Analysis of the protein kinase A and protein kinase C phosphorylation sites. J. Biol. Chem. 268:25054-25062; 1993.
10. 10. Ma, L.; Marquardt, D; Takemoto, L; Center, M. S. Analysis of P-glycoprotein phosphorylation in HL60 cells isolated for resistance to vincristine. J. Biol. Chem 266:5593-5599; 1991.
11. 11. Chambers, T. C.; Zheng, B.; Kuo, J. F. Regulation by phorbol ester and protein kinase C inhibitors and by a protein phosphatase inhibitor (okadaic acid), of P-glycoprotein phosphorylation and relationship to drug accumulation in multidrug resistant human KB cells. Mol. Pharmacol. 41:1008-1015; 1992.
12. 12. Bates, S. E.; Lee, J. S.; Dickstein, B.; Spolyar, M.; Fojo, A. T. Differential modulation of P-glycoprotein transport by protein kinase inhibition. Biochemistry 32:9156-9164; 1993.
13. 13. Sato, W.; Yusa, K.; Naito, M.; Tsuruo, T. Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug resistant cells. Biochem. Biophys. Res. Commun. 173:1252-1257; 1990.
14. 14. Sachs, C. W.; Safa, A. R.; Harrison, S. D.; Fine, R. L. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J. Biol. Chem. 270:26639-26648; 1995.
15. 15. Utz, I.; Hofer, S.; Regenass, U.; Hilbe, W.; Thaler, J.; Grunicke, H.; Hofmann, J. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumour activity, reverses multidrug resistance. Int. J. Cancer 57:104-110; 1994.
16. 16. Miyamoto, K. I.; Inoko, K.; Wakusawa, K.; Kajita, S.; Hasegawa, T.; Takagi, K.; Koyama, M. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo. Cancer Res. 53:1555-1559; 1993.
17. 17. Wakusawa, S. S.; Nakamura, S.; Tajima, K.; Miyamoto, K. I.; Hagiwara, M.; Hidaka, H. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in Adriamycin-resistant leukemia cells. Mol. Pharmacol. 41:1034-1038; 1992.
18. 18. Fine, R. L.; Patel, J.; Chabner, B. A. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA 85:582-586; 1988.
19. 19. Chambers, T. C.; Chalikonda, L; Eilon, G. Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem. Biophys. Res Commun. 169:253-259; 1990.
20. 20. Kessel, D. Effect of phorbol esters on doxorubicin transport systems. Biochem. Pharmacol. 37:2287-2299; 1988.
21. 21. Aftab, D. T.; Yang, J. M.; Hait, W. N. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug resistant MCF-7 cells. Oncol Res. 6:59-70; 1994.
22. I isoenzyme. Int. J. Oncol. 5:1227-1231; 1994.
23. 23. Dong, Z.; Ward, N. E.; Fan, D.; Gupta, K. P.; O'Brian, C. A. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Mol. Pharmacol. 39:563-569; 1991.
24. I confers a multidrug resistant phenotype on rat fibroblasts. Anticancer Res. 12:661-668; 1992.
25. 25. Aquino, A.; Warren, B. S.; Omichiniski, J.; Hartman, K. D.; Glazer, R. I. Protein kinase C γ is present in adriamycin resistant HL-60 leukemia cells. Biochem. Biophys. Res. Comm. 166:723-728; 1990.
26. 26. Germann, U. A.; Chambers, T. C.; Ambudkar, S.V.; Licht, T.; Cardarelli, C. O.; Pastan, I.; Gottesman, M. M. Characterisation of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J. Biol Chem. 271:1708-1716; 1995.
27. 27. Hug, H.; Sarre, T. F. Protein kinase C isoenzymes; divergence in signal transduction? Biochem. J. 291:329-343; 1993.
28. 28. Dekker, L.; Palmer, R. H.; Parker, P. J. The protein kinase C and protein kinase C related gene families. Curr. Opin. Struct. Biol. 5:396-402; 1995.
29. 29.Drew, L; Groome, N.; Hallam, T. J.; Warr, J. R.; Rumsby, M. G. Changes in protein kinase C subspecies protein expression and activity in a series of multidrug resistant human KB carcinoma cell lines. Oncol. Res. 6:429-438; 1994.
30. 30. Chaudhary, P. M.; Roninson, I. B. Activation of MDR 1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncol. Res. 4:281-290; 1992.
31. 31. Alon, N.; Busche, R.; Tummler, B.; Riordan, J. R. Membrane lipids of multidrug resistant cells: chemical composition and physical state. In: Roninson, I. B., ed. Molecular and cellular biology of multidrug resistance in tumour cells. New York: Plenum Press; 1991:pp. 263-276.
32. 32. Ling, V.; Carlsen, S. A.; See, Y. P. Altered drug permeability in mammalian cell mutants. In: Miller, M. W.; Shamoo, A. E., eds. Membrane toxicity. New York: Plenum Press; 1977:pp. 247-264.
33. 33. Ramu, A.; Glaubiger, D.; Weintraub, H. Differences in lipid composition of doxorubicin-sensitive and -resistant P388 cells. Cancer Treat. Rep. 68:637-641; 1984.
34. 34. Dudeja, P. K.; Anderson, K. M.; Harris, J. S.; Buckingham, L.; Coon, J. S. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane fluidity. Arch. Biochem. Biophys. 319:309-315; 1995.
35. 35. Ramu, A.; Ramu, N.; Rosario, L. M. Circumvention of multidrug resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine. Biochem. Pharmacol. 41:1455-1461; 1991.
36. 36. Kiss, Z. Effects of phorbol ester on phospholipid metabolism. Prog. Lipid Res. 29:141-166; 1990.
37. 37. Sharp, S. Y; Rogers, P. M.; Kelland, L. R. Transport of cisplatin and bis-acetato-ammine-dichlorocylohexy-lamine platinum (IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Clin. Cancer Res. 1:981-989; 1995.
38. 38. Fojo, A.; Akiyama, S.; Gottesman, M. M.; Pastan, I. Reduced drug accumulation in multiply drug resistant human KB carcinoma cell lines. Cancer Res. 45: 3002-3007; 1985.